Signature Financial Management’s AbbVie ABBV Stock Holding History

Signature Financial Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$318K	Buy	3,457 +300	+10%	+$26.4K	0.08%	89
2018 Q3	$300K	Hold	3,157	–	–	0.05%	119
2018 Q2	$293K	Sell	3,157 -935	-23%	-$91.3K	0.06%	123
2018 Q1	$388K	Hold	4,092	–	–	0.08%	96
2017 Q4	$396K	Sell	4,092 -2,756	-40%	-$260K	0.11%	84
2017 Q3	$538K	Buy	6,848 +1,250	+22%	+$95.2K	0.16%	81
2017 Q2	$407K	Buy	5,598 +1,127	+25%	+$75.8K	0.13%	94
2017 Q1	$292K	Hold	4,471	–	–	0.09%	113
2016 Q4	$281K	Hold	4,471	–	–	0.11%	111
2016 Q3	$283K	Hold	4,471	–	–	0.11%	106
2016 Q2	$277K	Hold	4,471	–	–	0.13%	94
2016 Q1	$255K	Sell	4,471 -866	-16%	-$48.3K	0.12%	101
2015 Q4	$318K	Buy	5,337 +100	+2%	+$5.76K	0.15%	72
2015 Q3	$285K	Buy	5,237 +1,960	+60%	+$128K	0.18%	71
2015 Q2	$221K	Buy	+3,277	New	+$214K	0.14%	87

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Signature Financial Management's ABBV Position: Q4 2018 in Review

Signature Financial Management increased its AbbVie (ABBV) stake by 9.5% in Q4 2018, buying an estimated $26.4K and bringing the position to 3,457 shares worth $318K. The position accounts for 0.08% of the portfolio, ranked #89.

Signature Financial Management first reported a position in ABBV in Q2 2015 and has held it in 15 quarters since. The position peaked at $538K in Q3 2017. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

Signature Financial Management held 3,457 shares of AbbVie worth $318K as of Q4 2018.
Signature Financial Management bought 300 AbbVie shares in Q4 2018, an estimated $26.4K.
AbbVie made up 0.08% of Signature Financial Management's portfolio in Q4 2018, its #89 holding.
Signature Financial Management first reported a position in AbbVie in Q2 2015 and has held it in 15 quarters since.
Signature Financial Management's AbbVie position peaked at $538K in Q3 2017.
2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Signature Financial Management's 13F filing for Q4 2018, filed 13 Feb 2019.